Catalyst Wire Dossier Catalyst Wire Dossier

Flumatinib

flumatinib · Jiangsu Hengrui Medicine Co., Ltd.
Drug timelines are a Plus or Pro feature.

10 regulatory and trial events tracked for Flumatinib, covering 2013-04-10 to 2025-05-01. Get the full timeline:

Most recent: Clinical Trial Update: Flumatinib Versus Imatinib Combined With Chemotherapy for de Novo Ph+ ALL [Phase 4]

See pricing